Private Market View

Alyssum Therapeutics

Cambridge, MA · Founded 2011 · Privately Held (backing)

Last price · $/share
Implied valuation
$13.3M
Total raised
$32.7M
Last round
What is Alyssum Therapeutics worth?
$13.3Mlast known valuation
Free account
See the evidence behind this price
  • ·The complete investor list — 10 names
  • ·Watchlist + deal alerts for Alyssum Therapeutics
  • ·The full record, as it builds
Create free account
No card required

Funding history

No rounds on record

No funding rounds for Alyssum Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Alyssum Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Alyssum Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Alyssum Therapeutics worth?
Alyssum Therapeutics's last known valuation is $13.3M.
How much has Alyssum Therapeutics raised?
Alyssum Therapeutics has raised $32.7M in total funding across its recorded rounds.